Mia's Feed
Medical News & Research

Innovative Approach to Creating 'Invisible' Stem Cells: Insights from Leading Scientist

Innovative Approach to Creating 'Invisible' Stem Cells: Insights from Leading Scientist

Share this article

2 min read

In recent advances in regenerative medicine, scientists have made significant progress toward developing hypoimmune stem cells—cells engineered to evade the immune system and reduce transplant rejection. Dr. Sonja Schrepfer, a prominent researcher at Cedars-Sinai Medical Center, discusses her pioneering work on these 'invisible' stem cells and their potential to revolutionize transplantation and cell therapy.

A longstanding challenge in organ and cell transplantation is immune rejection, which often necessitates lifelong immunosuppressive drugs. These drugs can have severe side effects, prompting researchers to seek alternative solutions. Genetic engineering offers a promising pathway to create stem cells that are less likely to be targeted by the immune system.

Dr. Schrepfer explains that her approach draws inspiration from natural immune tolerance mechanisms observed during pregnancy. The fetal cells during pregnancy employ hypoimmune strategies to avoid attack by the mother's immune defenses, despite being foreign genetically. By studying these mechanisms, she has developed methods using genome editing to modify stem cells, making them invisible—or hypoimmune—to the immune system.

She was among the first to utilize such gene edits, coining the term 'hypoimmune,' which has since been adopted by other research groups employing different strategies. These engineered stem cells can proliferate and differentiate into various cell types, including heart muscle cells, smooth muscle cells, and endothelial cells, expanding their potential applications.

The potential clinical applications are vast, including treatments for diseases such as ALS, retinitis pigmentosa, diabetes, and inflammatory bowel disease. Producing hypoimmune stem cells in large quantities could enable more accessible and universal cell therapies for patients worldwide.

Looking ahead, Dr. Schrepfer aims to extend this technology from cells to entire organs, aspiring to overcome barriers in solid organ transplantation. Initial experiments indicate this approach could prevent immune rejection of transplanted organs, opening new frontiers in medicine.

This innovative research marks a significant step toward universal donor cells and organs, promising to transform transplant medicine and patient care.

Source: https://medicalxpress.com/news/2025-04-qa-scientist-invisible-stem-cells.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

Advancing Prevention and Treatment of Colorectal Cancer in Black Communities

A comprehensive review highlights social, systemic, and environmental factors contributing to higher colorectal cancer rates in Black Americans and discusses effective strategies to bridge the health disparity gap.

Asthma Medication Zileuton Shows Promise in Preventing Severe Food Allergies in Mice

A Northwestern University study reveals that the FDA-approved asthma drug Zileuton can nearly eliminate severe food allergy reactions in mice, opening new possibilities for allergy treatment.

New Research Highlights How Skin Bacteria Help Protect Against Sun Damage

Discover how your skin's microbiome can naturally protect against sun damage by metabolizing UV-induced molecules, offering new insights into skin immunity and sun protection.

Innovative Oral Delivery System Could Replace Injections for Protein-Based Drugs

A novel oral delivery system developed by the University of Bath could enable protein-based medications to be taken as pills, replacing painful injections and improving patient compliance.